Nicotine Therapy in Patients with Alzheimer's Disease

Iversen LL , Iversen SD , Freedman SB , Dawson G , Rupniak N , Hargreaves RJ . Approaches to rational drug development in Alzheimer's disease. Drug Des Discov 1993; 9:251–9.

Fujimoto D , Shimomura SK . Alzheimer's disease. In: Herfindal ET , Gourley DR , Hart LL , eds. Clinical pharmacy and therapeutics. Baltimore: Williams and Wilkins, 1992: 1479–88.

Abramowicz M . Tacrine for Alzheimer's disease. Med Lett Drugs Ther 1993; 35:87–8.

Rinne JO , Myllykyla T , Lonnberg P , Marjamaki P . A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res 1991; 547:167–70.

Perry EK , Perry RH , Smith CJ , Dick DJ , Candy JM , Edwardson JA . Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1987; 50:806–9.

Whitehouse PJ , Martino AM , Antuono PG , Lowenstein PR , Coyle JT , Price DL . Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 1986; 371:146–51.

Whitehouse PJ , Martino AM , Marcus KA , Zweig RM , Singer HS , Price DL . Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch Neurol 1988; 45:722–4.

Balfour DJK . The effects of nicotine on brain neurotransmitter systems. Pharmacol Ther 1982; 16:269–82.

Levin ED . Nicotinic systems and cognitive function. Psychopharmacology 1992; 108:417–31.

Taylor P . Agents acting at the neuromuscular junction and autonomic ganglia. In: Gilman A , Nies AS , Rail TW , Taylor P , eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Pergamon Press, 1990: 166–86.

Gora ML . Nicotine transdermal systems. Ann Pharmacother 1993; 27:742–50.

Newhouse PA , Sunderland T , Tariot PN , Blumhardt CL , Weingartner H , Mellow A . Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 1988; 95:171–5.